| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.4 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |